tirzepatide with medicaid Which Weight Loss Meds Are Covered by Medicaid? The 2026 State-by-State Breakdown Tirzepatide: Injection Home Kit –

With semaglutides patent expiry expected around 2026, major Indian pharma companies are preparing for a massive generics wave

GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.

The difference in estimated risks with and without semaglutide treatment multiplied by the eligible NHANES weighted population represented the estimated preventable CVD events

Has the media leaned heavily on the merits of semaglutide and its brothers while ignoring the risks

Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease